- Home
- ARBB vs SNTI Comparison
ARBB vs SNTI Comparison
Compare ARBB & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- SNTI
- Stock Information
- Founded
- ARBB 1997
- SNTI 2016
- Country
- ARBB Singapore
- SNTI United States
- Employees
- ARBB N/A
- SNTI N/A
- Industry
- ARBB EDP Services
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- SNTI Health Care
- Exchange
- ARBB Nasdaq
- SNTI Nasdaq
- Market Cap
- ARBB 18.0M
- SNTI 17.8M
- IPO Year
- ARBB 2023
- SNTI N/A
- Fundamental
- Price
- ARBB $0.76
- SNTI $3.88
- Analyst Decision
- ARBB
- SNTI Strong Buy
- Analyst Count
- ARBB 0
- SNTI 1
- Target Price
- ARBB N/A
- SNTI $12.00
- AVG Volume (30 Days)
- ARBB 5.0M
- SNTI 19.5K
- Earning Date
- ARBB 04-26-2025
- SNTI 05-08-2025
- Dividend Yield
- ARBB N/A
- SNTI N/A
- EPS Growth
- ARBB N/A
- SNTI N/A
- EPS
- ARBB N/A
- SNTI N/A
- Revenue
- ARBB $12,334,474.00
- SNTI N/A
- Revenue This Year
- ARBB N/A
- SNTI N/A
- Revenue Next Year
- ARBB N/A
- SNTI N/A
- P/E Ratio
- ARBB N/A
- SNTI N/A
- Revenue Growth
- ARBB N/A
- SNTI N/A
- 52 Week Low
- ARBB $0.22
- SNTI $1.52
- 52 Week High
- ARBB $1.33
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- ARBB 53.75
- SNTI 61.60
- Support Level
- ARBB $0.53
- SNTI $2.80
- Resistance Level
- ARBB $1.09
- SNTI $3.24
- Average True Range (ATR)
- ARBB 0.10
- SNTI 0.37
- MACD
- ARBB 0.01
- SNTI 0.10
- Stochastic Oscillator
- ARBB 40.97
- SNTI 97.56
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.